NVTA Invitae Corp

  1. Stocks
  2. Healthcare
  3. NYSE: NVTA

Price (delayed)

$0.5082

Market cap

$145.6M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$5.24

Enterprise value

$1.49B

itae Corporation is a leading medical genetics company whose mission is to bring comprehensive genetic information into mainstream medicine to improve healthcare for billions of people. Invitae's goal is to ...

Highlights
NVTA's gross margin is up by 42% year-on-year and by 24% since the previous quarter
NVTA's gross profit is up by 31% year-on-year and by 21% since the previous quarter
The net income has plunged by 80% from the previous quarter but it has soared by 55% YoY
NVTA's EPS has dropped by 70% since the previous quarter but it has surged by 62% year-on-year
NVTA's quick ratio has dropped by 64% year-on-year and by 21% since the previous quarter
The revenue has contracted by 7% YoY and by 2.5% from the previous quarter
Sector: Healthcare
Industry: Diagnostics & Research
Website: http://www.invitae.com
Peers: CLDX CDNA AGIO

Key stats

What are the main financial stats of NVTA
Market
Shares outstanding
286.49M
Market cap
$145.6M
Enterprise value
$1.49B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
0.29
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
3.09
Earnings
Revenue
$481.58M
EBIT
-$1.42B
EBITDA
-$1.27B
Free cash flow
-$247.49M
Per share
EPS
-$5.24
Free cash flow per share
-$0.9
Book value per share
-$4.06
Revenue per share
$1.75
TBVPS
$1.94
Balance sheet
Total assets
$535.12M
Total liabilities
$1.62B
Debt
$1.51B
Equity
-$1.08B
Working capital
$219.98M
Liquidity
Debt to equity
-1.39
Current ratio
2.39
Quick ratio
2.19
Net debt/EBITDA
-1.06
Margins
EBITDA margin
-262.8%
Gross margin
27.1%
Net margin
-299.1%
Operating margin
-306.7%
Efficiency
Return on assets
-101%
Return on equity
N/A
Return on invested capital
-72.2%
Return on capital employed
-375.9%
Return on sales
-294%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

NVTA stock price

How has the Invitae stock price performed over time
Intraday
-1.78%
1 week
-6.43%
1 month
-16.41%
1 year
-82.89%
YTD
-72.68%
QTD
-16.03%

Financial performance

How have Invitae's revenue and profit performed over time
Revenue
$481.58M
Gross profit
$130.64M
Operating income
-$1.48B
Net income
-$1.44B
Gross margin
27.1%
Net margin
-299.1%
The company's operating margin has shrunk by 93% QoQ but it has surged by 51% YoY
The operating income has dropped by 88% since the previous quarter but it has soared by 54% year-on-year
NVTA's net margin has dropped by 85% since the previous quarter but it has surged by 52% year-on-year
The net income has plunged by 80% from the previous quarter but it has soared by 55% YoY

Growth

What is Invitae's growth rate over time

Valuation

What is Invitae stock price valuation
P/E
N/A
P/B
N/A
P/S
0.29
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
3.09
NVTA's EPS has dropped by 70% since the previous quarter but it has surged by 62% year-on-year
The stock's P/S is 97% less than its 5-year quarterly average of 9.1 and 52% less than its last 4 quarters average of 0.6
The revenue has contracted by 7% YoY and by 2.5% from the previous quarter

Efficiency

How efficient is Invitae business performance
The company's return on assets has shrunk by 127% QoQ and by 10% YoY
NVTA's ROIC has plunged by 102% from the previous quarter but it is up by 46% YoY
NVTA's return on sales has dropped by 91% since the previous quarter but it has surged by 52% year-on-year

Dividends

What is NVTA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for NVTA.

Financial health

How did Invitae financials performed over time
Invitae's total assets is 67% lower than its total liabilities
Invitae's total assets has shrunk by 74% YoY and by 65% QoQ
NVTA's quick ratio has dropped by 64% year-on-year and by 21% since the previous quarter
NVTA's debt to equity has dropped by 113% year-on-year but it has surged by 82% since the previous quarter
NVTA's debt is down by 14% year-on-year and by 4.7% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.